SCHEMBL1436752

SCHEMBL1436752

CC(=O)c1ccsc1S(=O)(=O)CN

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTK2 Q05397 1/20 0.37
KMT2A Q03164 4/20 0.35
ALDH1A1 P00352 3/20 0.35
MEN1 O00255 3/20 0.35
MAPT P10636 2/20 0.35
MAPK1 P28482 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KDM4E B2RXH2 2/20 0.33
RAB9A P51151 1/20 0.32
USP2 O75604 1/20 0.31
LMNA P02545 1/20 0.31
GLA P06280 1/20 0.31
HSD17B10 Q99714 1/20 0.31
POLB P06746 1/20 0.31
NR4A1 P22736 1/20 0.31
RECQL P46063 1/20 0.31
ESR2 Q92731 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CA2 P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3585261 0.82 CA2 (0.42) PTK2KMT2AALDH1A1MEN1MAPT
SCHEMBL334875 0.74 PTK2 (0.38) PTK2KMT2AALDH1A1MEN1MAPT
SCHEMBL7555210 0.69 NPSR1 (0.58) PTK2KMT2AALDH1A1MEN1MAPK1
SCHEMBL3044354 0.67
SCHEMBL4704966 0.66 MAPK1 (0.49) ALDH1A1MAPTMAPK1L3MBTL1KDM4E
SCHEMBL23531735 0.66 PTK2 (0.36) PTK2KMT2AALDH1A1MEN1MAPT
SCHEMBL4556834 0.65 PRNP (0.45) PTK2KMT2AALDH1A1MEN1MAPT
SCHEMBL1286667 0.65
SCHEMBL2083893 0.64 PTK2 (0.38) PTK2KMT2AALDH1A1MEN1MAPT
SCHEMBL15782809 0.64 PTK2 (0.38) PTK2KMT2AALDH1A1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0933354-B1 CALCIUM RECEPTOR-ACTIVE COMPOUNDS KYOWA HAKKO KIRIN CO LTD (JP) 2011-03-30 EP disclosed
US-6939895-B2 Calcium receptor-active compounds NPS PHARMACEUTICALS, INC. (US) 2005-09-06 US disclosed
US-6750255-B2 SUCH AS (R)-N-(1-(1'-NAPHTHYL)ETHYL)-2-(2',5'-DICHOROPHENYL THIO)ETHYLAMINE; FOR STIMULATION OF SECRETION OF PARATHYROID HORMONE NPS PHARMACEUTICALS, INC. 2004-06-15 US disclosed
US-20030176485-A1 Calcium receptor active compounds NPS PHARMACEUTICALS, INC. 2003-09-18 US disclosed
US-20030144526-A1 Calcium receptor-active compounds NPS PHARMACEUTICALS, INC. 2003-07-31 US disclosed
US-20020107406-A1 Calcium receptor-active compounds NPS PHARMACEUTICALS, INC. (US) 2002-08-08 US disclosed
US-6362231-B1 MODULATOR OF PARATHYROID HORMONE; OSTEOPOROSIS NPS PHARMACEUTICALS, INC. 2002-03-26 US disclosed
EP-0933354-A1 CALCIUM RECEPTOR-ACTIVE COMPOUNDS KIRIN BEER KABUSHIKI KAISHA (JP) 1999-08-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030144526-A1 Calcium receptor-active compounds CASR, CALCR, CNR1 PTK2 1459/4885KMT2A 2797/4885ALDH1A1 3470/4885
US-20030176485-A1 Calcium receptor active compounds CASR, CNR1, CALCR PTK2 1517/4885KMT2A 2794/4885ALDH1A1 3326/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.